Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06657950 · ClinicalTrials.gov registry record · NA

Treatments for Improving Mood in Women Survivors of Interpersonal Violence: A Community-Engaged Study-1.2

A NA study of Distress, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT06657950: Completed NA study of Distress, sponsored by Butler Hospital.

NCT06657950 is a NA study of Distress that has completed, run by Butler Hospital. The registered enrollment target is 11 participants, below the 121-participant average among 4 other Distress trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06657950, a NA study of Distress, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

Phase 1.2: Open Trial N=15 women survivors of interpersonal violence will be enrolled into a single-arm pilot trial to test the adapted integrative hatha yoga and mindful self-compassion program.

Primary Outcome

Feasibility assessed based on number of participants who remained in the intervention (retention).

Conditions Studied

Interventions

  • BEHAVIORAL Integrative hatha yoga and mindful self-compassion

Study Locations (1)

Rhode Island

  • Butler Hospital - Providence

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2024-09-10
Est. Completion 2025-05-30
Phase NA
Butler Hospital

103 total trials

What the finished NCT06657950 record still lists

NCT06657950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 121-participant average among 4 other Distress trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Distress appearing as the primary indexed condition, and to 1 intervention - of which Integrative hatha yoga and mindful self-compassion is the first listed.

NCT06657950 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06657950 about?

NCT06657950 is a clinical study titled "Treatments for Improving Mood in Women Survivors of Interpersonal Violence: A Community-Engaged Study-1.2". Phase 1.2: Open Trial N=15 women survivors of interpersonal violence will be enrolled into a single-arm pilot trial to test the adapted integrative hatha yoga and mindful self-compassion program.

What is the current status of trial NCT06657950?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-09-10. Estimated completion is 2025-05-30.

What conditions does trial NCT06657950 study?

This clinical trial studies the following conditions: Distress.

What interventions are being tested in trial NCT06657950?

The interventions under investigation include: Integrative hatha yoga and mindful self-compassion (BEHAVIORAL).

Who is sponsoring clinical trial NCT06657950?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06657950 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Distress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06657950, the US trial registry maintained by the National Library of Medicine. NCT06657950 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.